Ironwood Pharmaceuticals (IRWD) Cash from Operations (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Cash from Operations across 17 years of filings, most recently posting 5121000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 5121000.0, down 74.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 112211000.0 (up 42.91% YoY), and the FY2025 annual result was 127044000.0, up 22.69% from the prior year.
• Cash from Operations came in at 5121000.0 for Q1 2026 at Ironwood Pharmaceuticals, down from 74575000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 80171000.0 in Q1 2023 to a low of 15068000.0 in Q2 2025.
• The 5-year median for Cash from Operations is 35834000.0 (2023), against an average of 40759058.82.
• Peak annual rise in Cash from Operations reached 390.17% in 2025, while the deepest fall reached 145.03% in 2025.
• Ironwood Pharmaceuticals' Cash from Operations stood at 79182000.0 in 2022, then sank by 54.74% to 35834000.0 in 2023, then slumped by 57.54% to 15214000.0 in 2024, then soared by 390.17% to 74575000.0 in 2025, then sank by 93.13% to 5121000.0 in 2026.
• The last three Cash from Operations figures came in at 5121000.0 (Q1 2026), 74575000.0 (Q4 2025), and 47583000.0 (Q3 2025), per Business Quant data.